Pliant Therapeutics, Inc.PLRXNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank75
3Y CAGR+5.7%
5Y CAGR+22.3%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+5.7%/yr
vs +57.5%/yr prior
5Y CAGR
+22.3%/yr
Recent deceleration
Acceleration
-51.7pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
2.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$47.22M-20.0%
2024$59.05M+1.9%
2023$57.93M+45.0%
2022$39.95M+45.0%
2021$27.56M+59.6%
2020$17.27M+58.0%
2019$10.93M+68.2%
2018$6.50M+70.0%
2017$3.82M-